WisdomTree BioRevolution Fund (WDNA) Holdings
WDNA holdings summary
as of Oct 25, 2026- Holdings
- 83 positions listed
- Top 10 weight
- 28.4% of net assets
- Effective holdings
- 61 equal-weight equivalent
- Largest holding
- TWST 3.46% Twist Bioscience Corporation
- Annual turnover
- 11.5% of the portfolio traded
All WDNA holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | Healthcare | 3.46% | $160,320.36 | $8.80B | — |
| 2 | TEM | Tempus AI, Inc. | Healthcare | 3.45% | $159,690.93 | $11.68B | — |
| 3 | LLY | Eli Lilly and Company | Healthcare | 3.44% | $158,978.19 | $1.12T | 42.2 |
| 4 | NTRA | Natera, Inc. | Healthcare | 3.23% | $149,596.86 | $56.71B | — |
| 5 | IMNM | Immunome, Inc. | Healthcare | 2.90% | $134,300.70 | $1.94B | — |
| 6 | MRNA | Moderna, Inc. | Healthcare | 2.80% | $129,700.28 | $87.04B | — |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 2.47% | $114,181.98 | $255.13B | 37.1 |
| 8 | TXG | 10x Genomics, Inc. | Healthcare | 2.32% | $107,461.85 | $9.10B | — |
| 9 | UTHR | United Therapeutics Corporation | Healthcare | 2.17% | $100,408.50 | $22.87B | 19.1 |
| 10 | STOK | Stoke Therapeutics, Inc. | Healthcare | 2.16% | $99,880.88 | $1.56B | — |
| 11 | DAR | Darling Ingredients Inc. | Consumer Defensive | 1.81% | $83,742.40 | $9.68B | 16.5 |
| 12 | AMGN | Amgen Inc. | Healthcare | 1.78% | $82,525.18 | $233.82B | 26.9 |
| 13 | GILD | Gilead Sciences, Inc. | Healthcare | 1.78% | $82,154.93 | $193.67B | — |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.77% | $81,955.92 | $126.66B | 28.9 |
| 15 | ROIV | Roivant Sciences Ltd. | Healthcare | 1.71% | $79,095.70 | $24.22B | — |
| 16 | RVMD | Revolution Medicines, Inc. | Healthcare | 1.66% | $76,596.48 | $38.14B | — |
| 17 | PFE | Pfizer Inc. | Healthcare | 1.61% | $74,467.51 | $168.60B | 38.9 |
| 18 | KRYS | Krystal Biotech, Inc. | Healthcare | 1.53% | $70,857.53 | $9.37B | 39.7 |
| 19 | VYLR | Vylor Inc. | Financial Services | 1.51% | $70,075.36 | $48.17B | 103.1 |
| 20 | CGON | CG Oncology, Inc. | Healthcare | 1.49% | $68,913.69 | $5.31B | — |
| 21 | AZN | AstraZeneca PLC | Healthcare | 1.48% | $68,335.17 | — | — |
| 22 | CRSP | CRISPR Therapeutics AG | Healthcare | 1.48% | $68,321.28 | $4.76B | — |
| 23 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 1.46% | $67,608.54 | $1.87B | — |
| 24 | NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | 1.46% | $67,562.26 | — | — |
| 25 | BEAM | Beam Therapeutics Inc. | Healthcare | 1.29% | $59,860.96 | $2.42B | — |
| 26 | BAYN | Bayer AG NA | Healthcare | 1.28% | $59,194.50 | — | — |
| 27 | BHVN | Biohaven Ltd. | Healthcare | 1.20% | $55,663.19 | $1.63B | — |
| 28 | NOVN | Novartis AG | Healthcare | 1.20% | $55,510.46 | — | — |
| 29 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 1.18% | $54,598.71 | $2.67B | 10.0 |
| 30 | EXEL | Exelixis, Inc. | Healthcare | 1.16% | $53,617.53 | $15.42B | 19.6 |
| 31 | DYN | Dyne Therapeutics, Inc. | Healthcare | 1.15% | $53,238.02 | $2.66B | — |
| 32 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 1.14% | $52,553.05 | $12.98B | — |
| 33 | CAI | Caris Life Sciences, Inc. | Healthcare | 1.13% | $52,358.67 | $8.64B | 18.1 |
| 34 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 1.13% | $52,173.54 | $6.17B | — |
| 35 | GPCR | Structure Therapeutics Inc. | Healthcare | 1.12% | $51,761.63 | $1.50B | — |
| 36 | QURE | uniQure N.V. | Healthcare | 1.09% | $50,470.37 | $1.51B | — |
| 37 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 1.05% | $48,572.81 | $4.76B | — |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 1.05% | $48,568.18 | $31.02B | 39.1 |
| 39 | VCYT | Veracyte, Inc. | Healthcare | 1.04% | $48,281.24 | $3.47B | 30.8 |
| 40 | PRME | Prime Medicine, Inc. | Healthcare | 1.02% | $47,434.28 | $629.4M | — |
| 41 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 1.01% | $46,753.93 | $8.33B | 125.0 |
| 42 | XNCR | Xencor, Inc. | Healthcare | 1.00% | $46,305.00 | $1.70B | — |
| 43 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 0.99% | $45,786.64 | $3.17B | — |
| 44 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 0.99% | $45,768.13 | $13.83B | 35.6 |
| 45 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.98% | $45,518.21 | $1.69B | — |
| 46 | ABSI | Absci Corporation | Healthcare | 0.98% | $45,407.13 | $1.42B | — |
| 47 | GRAL | GRAIL, Inc. | Healthcare | 0.97% | $44,814.73 | $5.26B | — |
| 48 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.94% | $43,565.11 | $1.60B | — |
| 49 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.92% | $42,620.96 | $7.90B | — |
| 50 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.92% | $42,616.34 | $6.75B | — |
| 51 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.90% | $41,598.14 | $616.8M | — |
| 52 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 0.90% | $41,593.51 | $239.3M | — |
| 53 | ARGX | argenx SE | Healthcare | 0.90% | $41,551.85 | $51.51B | 31.2 |
| 54 | FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | 0.89% | $41,098.29 | $670.7M | — |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.89% | $41,038.13 | $7.14B | — |
| 56 | RGEN | Repligen Corporation | Healthcare | 0.87% | $40,436.46 | $11.14B | 240.3 |
| 57 | BIIB | Biogen Inc. | Healthcare | 0.87% | $40,154.14 | $34.37B | 41.3 |
| 58 | DHR | Danaher Corporation | Healthcare | 0.85% | $39,436.77 | $161.01B | 40.8 |
| 59 | BNTX | BioNTech SE | Healthcare | 0.80% | $37,011.60 | $22.03B | — |
| 60 | ILMN | Illumina, Inc. | Healthcare | 0.78% | $35,919.35 | $39.64B | 49.0 |
| 61 | ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | 0.73% | $33,878.32 | $293.9M | — |
| 62 | MRK | Merck & Co., Inc. | Healthcare | 0.73% | $33,670.05 | $360.08B | 115.8 |
| 63 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.72% | $33,392.36 | $794.7M | — |
| 64 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 0.70% | $32,374.16 | $2.16B | — |
| 65 | EDIT | Editas Medicine, Inc. | Healthcare | 0.65% | $30,120.23 | $360.9M | — |
| 66 | ONT | Oxford Nanopore Technologies Ltd | Healthcare | 0.65% | $29,902.71 | — | — |
| 67 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.63% | $29,305.67 | $81.41B | 19.6 |
| 68 | SYENS | Syensqo | Basic Materials | 0.62% | $28,731.78 | — | — |
| 69 | GMAB | Genmab A/S | Healthcare | 0.59% | $27,199.85 | $22.75B | 29.1 |
| 70 | QGEN | Qiagen N.V. | Healthcare | 0.57% | $26,491.74 | $9.53B | 23.4 |
| 71 | VBK | VERBIO Vereinigte BioEnergie AG | Basic Materials | 0.57% | $26,450.08 | — | — |
| 72 | VKTX | Viking Therapeutics, Inc. | Healthcare | 0.56% | $26,121.48 | $3.20B | — |
| 73 | ZTS | Zoetis Inc. | Healthcare | 0.56% | $25,783.62 | $32.80B | 13.1 |
| 74 | GNS | Genus PLC | Healthcare | 0.52% | $24,122.11 | — | — |
| 75 | NPCE | NeuroPace, Inc. | Healthcare | 0.52% | $24,094.34 | $420.1M | — |
| 76 | NUF | Nufarm Ltd | Basic Materials | 0.52% | $23,950.86 | — | — |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 0.49% | $22,877.12 | $1.43B | — |
| 78 | INSM | Insmed Incorporated | Healthcare | 0.48% | $22,428.19 | $21.02B | — |
| 79 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.48% | $22,368.02 | $10.58B | 147.8 |
| 80 | GPRE | Green Plains Inc. | Basic Materials | 0.47% | $21,817.27 | $1.01B | 9.0 |
| 81 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.45% | $20,863.86 | $452.6M | — |
| 82 | GERN | Geron Corporation | Healthcare | 0.44% | $20,507.49 | $751.7M | — |
| 83 | RGNX | REGENXBIO Inc. | Healthcare | 0.44% | $20,456.58 | $457.1M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($4.6M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
WDNA sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 93.6% | 76 | TWST, TEM, LLY |
| Basic Materials | 3.6% | 5 | NSIS-B, SYENS, VBK |
| Consumer Defensive | 1.8% | 1 | DAR |
| Financial Services | 1.5% | 1 | VYLR |
Sum of the weights of the holdings in each sector.
WDNA top industries
WDNA overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VTI | Vanguard Total Stock Market ETF | 4.2% | 64 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 4.1% | 14 of 502 | 0.09% |
| IWM | iShares Russell 2000 ETF | 3.5% | 38 of 1,962 | 0.19% |
| QQQ | Invesco QQQ ETF | 3.3% | 6 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 2.5% | 2 of 30 | 0.16% |
| VXUS | Vanguard Total International Stock ETF | 1.5% | 13 of 8,035 | 0.05% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the WDNA portfolio
WisdomTree BioRevolution Fund holds 83 positions. The ten largest make up 28.4% of the fund and the top 50 78.9%, so it behaves like a portfolio of about 61 equally weighted stocks. The biggest positions are Twist Bioscience Corporation (3.46%), Tempus AI, Inc. (3.45%), Eli Lilly and Company (3.44%), Natera, Inc. (3.23%), Immunome, Inc. (2.90%).
By sector, Healthcare is 93.6%, Basic Materials is 3.6%, Consumer Defensive is 1.8%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: WDNA chart, WDNA performance, WDNA dividends, WDNA overview.
WDNA holdings FAQ
How many holdings does WDNA have?
WDNA holds 83 positions as of October 25, 2026.
What are the top 10 holdings of WDNA?
The ten largest holdings are Twist Bioscience Corporation (3.46%), Tempus AI, Inc. (3.45%), Eli Lilly and Company (3.44%), Natera, Inc. (3.23%), Immunome, Inc. (2.90%), Moderna, Inc. (2.80%), Thermo Fisher Scientific Inc. (2.47%), 10x Genomics, Inc. (2.32%), United Therapeutics Corporation (2.17%), Stoke Therapeutics, Inc. (2.16%). Together they are 28.4% of the fund.
What percentage of WDNA is Twist Bioscience Corporation?
Twist Bioscience Corporation is the largest holding at 3.46% of net assets, about $160,320.36 of the fund's $4.6M.
Which sector is the largest in WDNA?
Healthcare is the largest sector at 93.6%, followed by Basic Materials (3.6%) and Consumer Defensive (1.8%), based on the sectors of the individual holdings.
How concentrated is WDNA?
The top 10 holdings are 28.4% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) WDNA behaves like a portfolio of about 61 equally weighted stocks.